Viewing Study NCT06265220

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:26 AM
Ignite Modification Date: 2026-02-20 @ 12:41 PM
Study NCT ID: NCT06265220
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-10
First Post: 2024-02-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus
Sponsor: Artiva Biotherapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lupus Nephritis - WHO Class III View
None Lupus Nephritis - WHO Class IV View
None Refractory Systemic Lupus Erythematosus View
None SLE View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SLE View
None Lupus View
None Lupus Nephritis View
None AlloNK View